Clinical Trial Update: MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates MR-guided adaptive radiotherapy combined with a PD-1 antibody and CAPOX chemotherapy for locally advanced rectal cancer; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Fudan University | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: RECRUITING